1185836-60-5Relevant articles and documents
TRICYCLIC COMPOUNDS
-
Paragraph 00336, (2017/08/01)
Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers or congenital diseases. Specific cancers and congenital disease includes those that are mediated by YAP/TAZ.
METHYLPYRROLOPYRIMIDINECARBOXAMIDES
-
Page/Page column 165-166, (2011/04/14)
The compounds of formula (I) wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, and the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiestera
PYRROLOPYRIMIDINECARBOXAMIDES
-
Page/Page column 185, (2009/10/21)
The compounds of Formula (I) wherein R1, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the N-oxides of the compounds and the salts thereof and the stereoisomers of the compounds, the salts, the N-oxides of